Abstract
There is a potential association between the dysregulation of trace elements and impaired liver function. Elevated levels of manganese, an essential metal ion, have been observed in liver-related diseases, and excessive intake of manganese can worsen liver damage. However, the specific mechanisms underlying manganese-induced liver injury are not well understood. The aim of our study was to investigate the effects of excess manganese on autoimmune hepatitis (AIH) and elucidate its mechanisms. Our findings revealed that manganese exacerbates liver damage under ConA-induced inflammatory conditions. Transcriptomic and experimental data suggested that manganese enhances inflammatory signaling and contributes to the inflammatory microenvironment in the liver of AIH mice. Further investigations demonstrated that manganese exacerbates liver injury by activating the cGAS-STING signaling pathway and its downstream pro-inflammatory factors such as IFN\(\alpha\), IFN\(\beta\), TNF\(\alpha\), and IL-6 in the liver of AIH mice. These results suggest that manganese overload promotes the progression of AIH by activating cGAS-STING-mediated inflammation, providing a new perspective for the treatment and prognosis of AIH.
Similar content being viewed by others
DATA AVAILABILITY
The data that support the findings of this study are available from the corresponding author upon reasonable request.
REFERENCES
Horning, K.J., S.W. Caito, K.G. Tipps, A.B. Bowman, and M. Aschner. 2015. Manganese is essential for neuronal health. Annual Review of Nutrition 35: 71–108.
Keen, C.L., J.L. Ensunsa, M.H. Watson, D.L. Baly, S.M. Donovan, M.H. Monaco, et al. 1999. Nutritional aspects of manganese from experimental studies. Neurotoxicology 20: 213–223.
Gandhi, D., A.P. Rudrashetti, and S. Rajasekaran. 2022. The impact of environmental and occupational exposures of manganese on pulmonary, hepatic, and renal functions. Journal of Applied Toxicology 42: 103–129.
O’Neal, S.L., and W. Zheng. 2015. Manganese toxicity upon overexposure: A decade in review. Current Environmental Health Reports 2: 315–328.
Nakayama, A., H. Fukuda, M. Ebara, H. Hamasaki, K. Nakajima, and H. Sakurai. 2002. A new diagnostic method for chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma based on serum metallothionein, copper, and zinc levels. Biological and Pharmaceutical Bulletin 25: 426–431.
Versieck, J., F. Barbier, A. Speecke, and J. Hoste. 1974. Manganese, copper, and zinc concentrations in serum and packed blood cells during acute hepatitis, chronic hepatitis, and posthepatitic cirrhosis. Clinical Chemistry 20: 1141–1145.
Liu, J., L. Tan, Z. Liu, and R. Shi. 2023. Blood and urine manganese exposure in non-alcoholic fatty liver disease and advanced liver fibrosis: An observational study. Environmental Science and Pollution Research International 30: 22222–22231.
Leyva-Illades, D., P. Chen, C.E. Zogzas, S. Hutchens, J.M. Mercado, C.D. Swaim, et al. 2014. SLC30A10 is a cell surface-localized manganese efflux transporter, and parkinsonism-causing mutations block its intracellular trafficking and efflux activity. Journal of Neuroscience 34: 14079–14095.
Quadri, M., A. Federico, T. Zhao, G.J. Breedveld, C. Battisti, C. Delnooz, et al. 2012. Mutations in SLC30A10 cause parkinsonism and dystonia with hypermanganesemia, polycythemia, and chronic liver disease. American Journal of Human Genetics 90: 467–477.
Ward, L.D., H.C. Tu, C.B. Quenneville, S. Tsour, A.O. Flynn-Carroll, M.M. Parker, et al. 2021. GWAS of serum ALT and AST reveals an association of SLC30A10 Thr95Ile with hypermanganesemia symptoms. Nature Communications 12: 4571.
Rashed, M.N. 2011. The role of trace elements on hepatitis virus infections: A review. Journal of Trace Elements in Medicine and Biology 25: 181–187.
Webb, G.J., G.M. Hirschfield, E.L. Krawitt, and M.E. Gershwin. 2018. Cellular and molecular mechanisms of autoimmune hepatitis. Annual Review of Pathology: Mechanisms of Disease 13: 247–292.
Fan, J.H., G.F. Liu, X.D. Lv, R.Z. Zeng, L.L. Zhan, and X.P. Lv. 2021. Pathogenesis of autoimmune hepatitis. World Journal of Hepatology 13: 879–886.
Floreani, A., P. Restrepo-Jiménez, M.F. Secchi, S. De Martin, P.S.C. Leung, E. Krawitt, et al. 2018. Etiopathogenesis of autoimmune hepatitis. Journal of Autoimmunity 95: 133–143.
Jones, D.B., and C.O. Johns. 1916. Some proteins from the jack bean, Canavalia Ensiformis. Journal of Biological Chemistry 28: 67–75.
Tiegs, G., J. Hentschel, and A. Wendel. 1992. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. The Journal of Clinical Investigation 90: 196–203.
Liu, Y., H. Hao, and T. Hou. 2022. Concanavalin A-induced autoimmune hepatitis model in mice: Mechanisms and future outlook. Open Life Sciences 17: 91–101.
Kusters, S., F. Gantner, G. Kunstle, and G. Tiegs. 1996. Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. Gastroenterology 111: 462–471.
Srisuchart, B., M.J. Taylor, and R.P. Sharma. 1987. Alteration of humoral and cellular immunity in manganese chloride-treated mice. Journal of Toxicology and Environment Health 22: 91–99.
Wang, C., Y. Guan, M. Lv, R. Zhang, Z. Guo, X. Wei, et al. 2018. Manganese increases the sensitivity of the cGAS-STING pathway for double-stranded DNA and Is required for the host defense against DNA viruses. Immunity 48: 675-687.e7.
Zhang, R., W. Yang, H. Zhu, J. Zhai, M. Xue, and C. Zheng. 2023. NLRC4 promotes the cGAS-STING signaling pathway by facilitating CBL-mediated K63-linked polyubiquitination of TBK1. Journal of Medical Virology 95: e29013.
Xu, H., C. Su, A. Pearson, C.H. Mody, and C. Zheng. 2017. Herpes Simplex Virus 1 UL24 abrogates the DNA sensing signal pathway by inhibiting NF-κB activation. Journal of Virology 91: e00025-17.
Chen, K., C. Lai, Y. Su, W.D. Bao, L.N. Yang, P.P. Xu, et al. 2022. cGAS-STING-mediated IFN-I response in host defense and neuroinflammatory diseases. Current Neuropharmacology 20: 362–371.
García-Buey, L., C. García-Monzón, S. Rodriguez, M.J. Borque, A. García-Sánchez, R. Iglesias, et al. 1995. Latent autoimmune hepatitis triggered during interferon therapy in patients with chronic hepatitis C. Gastroenterology 108: 1770–1777.
Villamil, A., E. Mullen, P. Casciato, and A. Gadano. 2015. Interferon beta 1a-induced severe autoimmune hepatitis in patients with multiple sclerosis: Report of two cases and review of the literature. Annals of Hepatology 14: 273–280.
Hao, J., W. Sun, and H. Xu. 2022. Pathogenesis of concanavalin A induced autoimmune hepatitis in mice. International Immunopharmacology 102: 108411.
Decout, A., J.D. Katz, S. Venkatraman, and A. Ablasser. 2021. The cGAS-STING pathway as a therapeutic target in inflammatory diseases. Nature Reviews Immunology 21: 548–569.
Grivennikov, S.I., A.V. Tumanov, D.J. Liepinsh, A.A. Kruglov, B.I. Marakusha, A.N. Shakhov, et al. 2005. Distinct and nonredundant in vivo functions of TNF produced by t cells and macrophages/neutrophils: Protective and deleterious effects. Immunity 22: 93–104.
Mizuhara, H., E. O’Neill, N. Seki, T. Ogawa, C. Kusunoki, K. Otsuka, et al. 1994. T cell activation-associated hepatic injury: Mediation by tumor necrosis factors and protection by interleukin 6. Journal of Experimental Medicine 179: 1529–1537.
Brenner, C., L. Galluzzi, O. Kepp, and G. Kroemer. 2013. Decoding cell death signals in liver inflammation. Journal of Hepatology 59: 583–594.
Knight, B., R. Lim, G.C. Yeoh, and J.K. Olynyk. 2007. Interferon-gamma exacerbates liver damage, the hepatic progenitor cell response and fibrosis in a mouse model of chronic liver injury. Journal of Hepatology 47: 826–833.
Toyonaga, T., O. Hino, S. Sugai, S. Wakasugi, K. Abe, M. Shichiri, et al. 1994. Chronic active hepatitis in transgenic mice expressing interferon-gamma in the liver. Proceedings of the National Academy of Sciences of the United States of America 91: 614–618.
Miyagi, T., T. Takehara, T. Tatsumi, T. Suzuki, M. Jinushi, Y. Kanazawa, et al. 2004. Concanavalin a injection activates intrahepatic innate immune cells to provoke an antitumor effect in murine liver. Hepatology 40: 1190–1196.
Ivashkiv, L.B., and L.T. Donlin. 2014. Regulation of type I interferon responses. Nature Reviews Immunology 14: 36–49.
Su, C., Y.D. Tang, and C. Zheng. 2021. DExD/H-box helicases: Multifunctional regulators in antiviral innate immunity. Cellular and Molecular Life Sciences 79: 2.
Berardi, S., F. Lodato, A. Gramenzi, A. D’Errico, M. Lenzi, A. Bontadini, et al. 2007. High incidence of allograft dysfunction in liver transplanted patients treated with pegylated-interferon alpha-2b and ribavirin for hepatitis C recurrence: Possible de novo autoimmune hepatitis? Gut 56: 237–242.
Hong, Z., J. Mei, H. Guo, J. Zhu, and C. Wang. 2022. Intervention of cGAS‒STING signaling in sterile inflammatory diseases. Journal of Molecular Cell Biology 14: mjac005.
Zhang, R., C. Wang, Y. Guan, X. Wei, M. Sha, M. Yi, et al. 2021. Manganese salts function as potent adjuvants. Cellular & Molecular Immunology 18: 1222–1234.
Xu, D., Y. Tian, Q. Xia, and B. Ke. 2021. The cGAS-STING pathway: Novel perspectives in liver diseases. Frontiers in Immunology 12: 682736.
Skopelja-Gardner, S., J. An, and K.B. Elkon. 2022. Role of the cGAS-STING pathway in systemic and organ-specific diseases. Nature Reviews Nephrology 18: 558–572.
Motwani, M., S. Pesiridis, and K.A. Fitzgerald. 2019. DNA sensing by the cGAS-STING pathway in health and disease. Nature Reviews Genetics 20: 657–674.
Wang, S., K. Wang, R. Lin, and C. Zheng. 2013. Herpes simplex virus 1 serine/threonine kinase US3 hyperphosphorylates IRF3 and inhibits beta interferon production. Journal of Virology 87: 12814–12827.
Papo, T., P. Marcellin, J. Bernuau, F. Durand, T. Poynard, and J.P. Benhamou. 1992. Autoimmune chronic hepatitis exacerbated by alpha-interferon. Annals of Internal Medicine 116: 51–53.
Tana, M.M., A. Klepper, A. Lyden, A.O. Pisco, M. Phelps, B. McGee, et al. 2022. Transcriptomic profiling of blood from autoimmune hepatitis patients reveals potential mechanisms with implications for management. PLoS ONE 17: e0264307.
ACKNOWLEDGEMENTS
The authors thank Putuo People’s Hospital, Shanghai Key Laboratory of Signaling and Disease Research, School of Life Sciences and Technology, Tongji University, Shanghai, China.
Funding
This work was supported by grants from the National Natural Science Foundation of China (32270754 and 32070768).
Author information
Authors and Affiliations
Contributions
All authors participated in the study and supported the publication of the final version. (I) Design and experimentation: Kaidireya Saimaier, Sanxing Han, Ling Xie, Chun Wang, Jie Lv, Wei Zhuang Guangyu Liu, Ru Zhang, Qiuhong Hua, and Changjie Shi; (II) supervision: Changsheng Du; (III) manuscript writing: Kaidireya Saimaier and Changsheng Du.
Corresponding author
Ethics declarations
Ethical Approval
All animal experiments were conducted following the line of legislation and ethical guidelines of the People’s Republic of China.
Consent for Participation and Publication
This is not applicable.
Competing Interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Saimaier, K., Han, S., Lv, J. et al. Manganese Exacerbates ConA-Induced Liver Inflammation via the cGAS-STING Signaling Pathway. Inflammation 47, 333–345 (2024). https://doi.org/10.1007/s10753-023-01912-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-023-01912-4